The Department of Health Abu Dhabi (DoH), the healthcare regulator in the Emirate, signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, a leading global research-driven pharmaceutical company. The agreement, signed during the BIO International Convention 2025, the world’s largest biotechnology conference, aims to advance scientific research and innovation, support innovative R&D initiatives, and foster … Abu Dhabi Strengthens Life Sciences Position Through Strategic Partnership with Boehringer Ingelheim at US BIO 2025 Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.